Long-Term Survival Rates of Some Acute Myeloid Leukemia Patients Could Double With Sensitive Bone Marrow Test Apr. 28, 2025 — A highly sensitive bone marrow test could double survival rates for ...

Acute myelogenous leukemia, or AML, remains one of the most aggressive blood cancers. Each year, around 44,000 people in the ...

Researchers sought to determine whether the ALL-Hematotox would be able to predict hematotoxicity for patients with B-ALL who are at risk of severe hematotoxicity following CAR-T therapy.

Doctors highlighted the need for a comprehensive national strategy to tackle AML and the need for recognising the ...

With rising cases of acute myeloid leukemia (AML), a type of blood cancer, experts are calling for it to be recognised as a national health priority, saying critical time is lost in its detection ...